Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


30.01.2017

1 Acta Ophthalmol
1 Am J Med
2 Ann Intern Med
1 BMJ
1 Br J Ophthalmol
7 Diabetes
9 Diabetes Care
8 Diabetes Educ
10 Diabetes Obes Metab
6 Diabetologia
3 Invest Ophthalmol Vis Sci
3 J Am Coll Cardiol
2 J Clin Invest
2 J Hypertens
1 J Nutr
7 JAMA
1 Kidney Int
3 Lancet Diabetes Endocrinol
2 N Engl J Med
5 Pediatr Diabetes
8 PLoS One
1 Retina


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Ophthalmol

  1. BELTRAMO E, Arroba AI, Mazzeo A, Valverde AM, et al
    Imbalance between pro-apoptotic and pro-survival factors in human retinal pericytes in diabetic-like conditions.
    Acta Ophthalmol. 2017 Jan 27. doi: 10.1111/aos.13377.
    PubMed     Text format     Abstract available


    Am J Med

  2. KASMARI A, Welch A, Liu G, Leslie D, et al
    Independent of Cirrhosis, Hepatocellular Carcinoma risk is increased with Diabetes and Metabolic Syndrome: A retrospective cohort study.
    Am J Med. 2017 Jan 18. pii: S0002-9343(17)30034.
    PubMed     Text format     Abstract available


    Ann Intern Med

  3. BROPHY J
    Review: In type 2 diabetes, sodium-glucose cotransporter 2 inhibitors do not increase major CV events or mortality.
    Ann Intern Med. 2017;166:JC7.
    PubMed     Text format    

  4. DONATO AA
    Semaglutide reduced a composite of CV events at 2 years in patients with type 2 diabetes and high CV risk.
    Ann Intern Med. 2017;166:JC8.
    PubMed     Text format    


    BMJ

  5. WISE J
    Continuous glucose monitoring can benefit patients with type 1 diabetes.
    BMJ. 2017;356:j364.
    PubMed     Text format    


    Br J Ophthalmol

  6. NERIYANURI S, Pardhan S, Gella L, Pal SS, et al
    Retinal sensitivity changes associated with diabetic neuropathy in the absence of diabetic retinopathy.
    Br J Ophthalmol. 2017 Jan 20. pii: bjophthalmol-2016-309641.
    PubMed     Text format     Abstract available


    Diabetes


  7. In This Issue of Diabetes.
    Diabetes. 2017;66:233-234.
    PubMed     Text format    

  8. HEUTS F, Edner NM, Walker LS
    Follicular T Helper Cells: A New Marker of Type 1 Diabetes Risk?
    Diabetes. 2017;66:258-260.
    PubMed     Text format    

  9. ABCOUWER SF
    Muller Cell-Microglia Cross Talk Drives Neuroinflammation in Diabetic Retinopathy.
    Diabetes. 2017;66:261-263.
    PubMed     Text format    

  10. TAKIISHI T, Cook DP, Korf H, Sebastiani G, et al
    Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10-Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells.
    Diabetes. 2017;66:448-459.
    PubMed     Text format     Abstract available

  11. MASTROLIA V, Flucher SM, Obermair GJ, Drach M, et al
    Loss of alpha2delta-1 Calcium Channel Subunit Function Increases the Susceptibility for Diabetes.
    Diabetes. 2017 Jan 23. pii: db151349. doi: 10.2337/db16-0336.
    PubMed     Text format     Abstract available

  12. RATTER JM, Rooijackers HM, Tack CJ, Hijmans AG, et al
    Pro-inflammatory Effects of Hypoglycemia in Humans with or without Diabetes.
    Diabetes. 2017 Jan 23. pii: db161091. doi: 10.2337/db16-1091.
    PubMed     Text format     Abstract available

  13. VIISANEN T, Ihantola EL, Nanto-Salonen K, Hyoty H, et al
    Circulating CXCR5+PD-1+ICOS+ Follicular T Helper Cells Are Increased Close to the Diagnosis of Type 1 Diabetes in Children With Multiple Autoantibodies.
    Diabetes. 2017;66:437-447.
    PubMed     Text format     Abstract available


    Diabetes Care

  14. GARVEY WT
    Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201.
    Diabetes Care. 2017;40:e21-e22.
    PubMed     Text format    


  15. In This Issue of Diabetes Care.
    Diabetes Care. 2017;40:159-160.
    PubMed     Text format    

  16. WHELTON SP, McEvoy JW, Lazo M, Coresh J, et al
    High-Sensitivity Cardiac Troponin T (hs-cTnT) as a Predictor of Incident Diabetes in the Atherosclerosis Risk in Communities Study.
    Diabetes Care. 2017;40:261-269.
    PubMed     Text format     Abstract available

  17. CEFALU WT, Buse JB, Tuomilehto J, Fleming GA, et al
    Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201.
    Diabetes Care. 2017;40:e23-e24.
    PubMed     Text format    

  18. HOME PD
    Comment on Pathak et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011. Diabetes Care 2016:39;363-370.
    Diabetes Care. 2017;40:e25.
    PubMed     Text format    

  19. PATHAK RD, Schroeder EB, Seaquist ER, Zeng C, et al
    Response to Comment on Pathak et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011. Diabetes Care 2016;39:363-370.
    Diabetes Care. 2017;40:e26.
    PubMed     Text format    

  20. BERGENSTAL RM, Bailey TS, Rodbard D, Ziemen M, et al
    Comparison of Insulin Glargine 300 U/mL and 100 U/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections.
    Diabetes Care. 2017 Jan 23. pii: dc160684. doi: 10.2337/dc16-0684.
    PubMed     Text format     Abstract available

  21. LI X, Campbell-Thompson M, Wasserfall CH, McGrail K, et al
    Serum Trypsinogen Levels in Type 1 Diabetes.
    Diabetes Care. 2017 Jan 23. pii: dc161774. doi: 10.2337/dc16-1774.
    PubMed     Text format     Abstract available

  22. SHAH AS, Maahs DM, Stafford JM, Dolan LM, et al
    Predictors of Dyslipidemia Over Time in Youth With Type 1 Diabetes: For the SEARCH for Diabetes in Youth Study.
    Diabetes Care. 2017 Jan 26. pii: dc162193. doi: 10.2337/dc16-2193.
    PubMed     Text format     Abstract available


    Diabetes Educ

  23. JOHNSON JA, Cavanagh S, Jacelon CS, Chasan-Taber L, et al
    The Diabetes Disparity and Puerto Rican Identified Individuals.
    Diabetes Educ. 2017 Jan 1:145721716687662. doi: 10.1177/0145721716687662.
    PubMed     Text format     Abstract available

  24. POWERS MA, Bardsley J, Cypress M, Duker P, et al
    Diabetes Self-management Education and Support in Type 2 Diabetes.
    Diabetes Educ. 2017;43:40-53.
    PubMed     Text format    


  25. Role of the Diabetes Educator in Inpatient Diabetes Management.
    Diabetes Educ. 2017;43:28-33.
    PubMed     Text format     Abstract available

  26. BRANOFF JD, Jiroutek MR, Kelly CR, Huma S, et al
    A Retrospective Cross-sectional Analysis of Health Education Disparities in Patients With Diabetes Using Data From the National Ambulatory Medical Care Survey.
    Diabetes Educ. 2017;43:125-134.
    PubMed     Text format     Abstract available


  27. Management of Children With Diabetes in the School Setting.
    Diabetes Educ. 2017;43:34-39.
    PubMed     Text format     Abstract available

  28. AGARWAL S, Raymond JK, Schutta MH, Cardillo S, et al
    An Adult Health Care-Based Pediatric to Adult Transition Program for Emerging Adults With Type 1 Diabetes.
    Diabetes Educ. 2017;43:87-96.
    PubMed     Text format     Abstract available

  29. RAMCHANDANI N, Johnson K, Cullen K, Hamm T, et al
    CDE Perspectives of Providing New-Onset Type 1 Diabetes Education Using Formal Vignettes and Simulation.
    Diabetes Educ. 2017;43:97-104.
    PubMed     Text format     Abstract available

  30. LAGISETTY PA, Priyadarshini S, Terrell S, Hamati M, et al
    Culturally Targeted Strategies for Diabetes Prevention in Minority Population.
    Diabetes Educ. 2017;43:54-77.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  31. STORGAARD H, Cold F, Gluud LL, Vilsboll T, et al
    Glucagon-Like Peptide-1 Agonists and Risk of Acute Pancreatitis in Patients with Type 2 Diabetes.
    Diabetes Obes Metab. 2017 Jan 20. doi: 10.1111/dom.12885.
    PubMed     Text format     Abstract available

  32. VON SCHOLTEN BJ, Persson F, Rosenlund S, Eugen-Olsen J, et al
    Liraglutide effects on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomised, placebo-controlled, double-blind, cross-over trial.
    Diabetes Obes Metab. 2017 Jan 20. doi: 10.1111/dom.12884.
    PubMed     Text format     Abstract available

  33. RATHMANN W, Strassburger K, Bongaerts B, Bobrov P, et al
    Impact of Insulin Sensitivity, Beta-cell Function and Glycemic Control on Initiation of Second-Line Glucose-Lowering Treatment in Newly Diagnosed Type 2 Diabetes.
    Diabetes Obes Metab. 2017 Jan 27. doi: 10.1111/dom.12894.
    PubMed     Text format     Abstract available

  34. GRAY SG, McGuire T, Cohen N, Little PJ, et al
    The emerging role of Metformin in Gestational Diabetes Mellitus.
    Diabetes Obes Metab. 2017 Jan 27. doi: 10.1111/dom.12893.
    PubMed     Text format     Abstract available

  35. ANHOLM C, Kumarathurai P, Pedersen LR, Nielsen OW, et al
    Liraglutide effects on beta-cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes.
    Diabetes Obes Metab. 2017 Jan 26. doi: 10.1111/dom.12891.
    PubMed     Text format     Abstract available

  36. HUNT B, Vega-Hernandez G, Valentine WJ, Kragh N, et al
    Evaluation of the long-term cost-effectiveness of liraglutide versus lixisenatide for treatment of type 2 diabetes mellitus in the UK setting.
    Diabetes Obes Metab. 2017 Jan 26. doi: 10.1111/dom.12890.
    PubMed     Text format     Abstract available

  37. HARRIS SB, Kocsis G, Prager R, Ridge T, et al
    Safety and Efficacy of IDegLira Titrated Once Weekly versus Twice Weekly in Patients with Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs: DUAL VI Randomized Clinical Trial.
    Diabetes Obes Metab. 2017 Jan 26. doi: 10.1111/dom.12892.
    PubMed     Text format     Abstract available

  38. NYSTROM T, Bodegard J, Nathanson D, Thuresson M, et al
    Novel oral glucose-lowering drugs compared to insulin are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycemia in type 2 diabetes patients.
    Diabetes Obes Metab. 2017 Jan 24. doi: 10.1111/dom.12889.
    PubMed     Text format     Abstract available

  39. JI L, Zhang P, Zhu D, Li X, et al
    Observational Registry of Basal Insulin Treatment (ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real-life use of basal insulin in China.
    Diabetes Obes Metab. 2017 Jan 20. doi: 10.1111/dom.12886.
    PubMed     Text format     Abstract available

  40. TERRA SG, Focht K, Davies M, Frias J, et al
    A Phase 3, Efficacy and Safety Study of Ertugliflozin Monotherapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Diet and Exercise Alone.
    Diabetes Obes Metab. 2017 Jan 24. doi: 10.1111/dom.12888.
    PubMed     Text format     Abstract available


    Diabetologia

  41. FRANKS PW, Poveda A
    Lifestyle and precision diabetes medicine: will genomics help optimise the prediction, prevention and treatment of type 2 diabetes through lifestyle therapy?
    Diabetologia. 2017 Jan 25. doi: 10.1007/s00125-017-4207.
    PubMed     Text format     Abstract available

  42. FARMER AD, Pedersen AG, Brock B, Jakobsen PE, et al
    Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profile.
    Diabetologia. 2017 Jan 20. doi: 10.1007/s00125-016-4199.
    PubMed     Text format     Abstract available

  43. LAW GR, Gilthorpe MS, Secher AL, Temple R, et al
    Translating HbA1c measurements into estimated average glucose values in pregnant women with diabetes.
    Diabetologia. 2017 Jan 19. doi: 10.1007/s00125-017-4205.
    PubMed     Text format     Abstract available

  44. LUNDBERG M, Seiron P, Ingvast S, Korsgren O, et al
    Re-addressing the 2013 consensus guidelines for the diagnosis of insulitis in human type 1 diabetes: is change necessary? Reply to Campbell-Thompson ML, Atkinson MA, Butler AE et al [letter].
    Diabetologia. 2017 Jan 22. doi: 10.1007/s00125-017-4212.
    PubMed     Text format    

  45. ABDELSAID M, Coucha M, Hafez S, Yasir A, et al
    Enhanced VEGF signalling mediates cerebral neovascularisation via downregulation of guidance protein ROBO4 in a rat model of diabetes.
    Diabetologia. 2017 Jan 23. doi: 10.1007/s00125-017-4214.
    PubMed     Text format     Abstract available

  46. CHEN P, Piaggi P, Traurig M, Bogardus C, et al
    Differential methylation of genes in individuals exposed to maternal diabetes in utero.
    Diabetologia. 2017 Jan 26. doi: 10.1007/s00125-016-4203.
    PubMed     Text format     Abstract available


    Invest Ophthalmol Vis Sci

  47. THOMAS AA, Feng B, Chakrabarti S
    ANRIL: A Regulator of VEGF in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:470-480.
    PubMed     Text format     Abstract available

  48. DIMITROVA G, Chihara E, Takahashi H, Amano H, et al
    Quantitative Retinal Optical Coherence Tomography Angiography in Patients With Diabetes Without Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:190-196.
    PubMed     Text format     Abstract available

  49. GHASEMI FALAVARJANI K, Iafe NA, Hubschman JP, Tsui I, et al
    Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
    Invest Ophthalmol Vis Sci. 2017;58:30-34.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  50. PICCINI JP, Granger CB
    Insulin Therapy and Stroke Risk in Patients With Diabetes and Atrial Fibrillation: Guilty by Association?
    J Am Coll Cardiol. 2017;69:420-422.
    PubMed     Text format    

  51. PATTI G, Lucerna M, Cavallari I, Ricottini E, et al
    Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF.
    J Am Coll Cardiol. 2017;69:409-419.
    PubMed     Text format     Abstract available

  52. SERRUYS PW, Farooq V
    Cherry-Picking Historical Data to Legitimize Contemporary Practice: Should Diabetic Status Influence Decision-Making in Complex CAD?
    J Am Coll Cardiol. 2017;69:404-408.
    PubMed     Text format    


    J Clin Invest

  53. PERRY RJ, Peng L, Abulizi A, Kennedy L, et al
    Mechanism for leptin's acute insulin-independent effect to reverse diabetic ketoacidosis.
    J Clin Invest. 2017 Jan 23. pii: 88477. doi: 10.1172/JCI88477.
    PubMed     Text format     Abstract available

  54. OBERLIN D, Buettner C
    How does leptin restore euglycemia in insulin-deficient diabetes?
    J Clin Invest. 2017 Jan 23. pii: 91880. doi: 10.1172/JCI91880.
    PubMed     Text format     Abstract available


    J Hypertens

  55. KUMARATHURAI P, Anholm C, Fabricius-Bjerre A, Nielsen OW, et al
    Effects of the glucagon-like peptide-1 receptor agonist liraglutide on 24-h ambulatory blood pressure in patients with type 2 diabetes and stable coronary artery disease: a randomized, double-blind, placebo-controlled, crossover study.
    J Hypertens. 2017 Jan 27. doi: 10.1097/HJH.0000000000001275.
    PubMed     Text format     Abstract available

  56. DASGUPTA K, Rosenberg E, Joseph L, Trudeau L, et al
    Carotid femoral pulse wave velocity in type 2 diabetes and hypertension: capturing arterial health effects of step counts.
    J Hypertens. 2017 Jan 27. doi: 10.1097/HJH.0000000000001277.
    PubMed     Text format     Abstract available


    J Nutr

  57. FARROKHIAN A, Raygan F, Bahmani F, Talari HR, et al
    Long-Term Vitamin D Supplementation Affects Metabolic Status in Vitamin D-Deficient Type 2 Diabetic Patients with Coronary Artery Disease.
    J Nutr. 2017 Jan 25. pii: jn242008. doi: 10.3945/jn.116.242008.
    PubMed     Text format     Abstract available


    JAMA

  58. DAVIDSON MB
    Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections.
    JAMA. 2017;317:363-364.
    PubMed     Text format    

  59. LIPSKA KJ, Krumholz HM
    Is Hemoglobin A1c the Right Outcome for Studies of Diabetes?
    JAMA. 2017 Jan 26. doi: 10.1001/jama.2017.0029.
    PubMed     Text format    

  60. CHAN M
    China's Burgeoning Epidemic of Diabetes-Associated Mortality.
    JAMA. 2017;317:264-266.
    PubMed     Text format    

  61. LIND M, Polonsky W, Hirsch IB, Heise T, et al
    Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    JAMA. 2017;317:379-387.
    PubMed     Text format     Abstract available

  62. VOELKER R
    Diabetes Drug Gains New Indication.
    JAMA. 2017;317:247.
    PubMed     Text format    

  63. BECK RW, Riddlesworth T, Ruedy K, Ahmann A, et al
    Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    JAMA. 2017;317:371-378.
    PubMed     Text format     Abstract available

  64. BRAGG F, Holmes MV, Iona A, Guo Y, et al
    Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China.
    JAMA. 2017;317:280-289.
    PubMed     Text format     Abstract available


    Kidney Int

  65. LI HY, Oh YS, Choi JW, Jung JY, et al
    Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice.
    Kidney Int. 2017 Jan 19. pii: S0085-2538(16)30681.
    PubMed     Text format     Abstract available


    Lancet Diabetes Endocrinol

  66. SORLI C, Harashima SI, Tsoukas GM, Unger J, et al
    Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial.
    Lancet Diabetes Endocrinol. 2017 Jan 16. pii: S2213-8587(17)30013.
    PubMed     Text format     Abstract available

  67. RIDDELL MC, Gallen IW, Smart CE, Taplin CE, et al
    Exercise management in type 1 diabetes: a consensus statement.
    Lancet Diabetes Endocrinol. 2017 Jan 23. pii: S2213-8587(17)30014.
    PubMed     Text format     Abstract available

  68. MUTLUOGLU M, Lipsky BA
    Non-surgical treatment of diabetic foot osteomyelitis.
    Lancet Diabetes Endocrinol. 2017 Jan 17. pii: S2213-8587(16)30141.
    PubMed     Text format    


    N Engl J Med

  69. ALVAREZ-VILLALOBOS NA, Trevino-Alvarez AM, Gonzalez-Gonzalez JG
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797-8.
    PubMed     Text format    

  70. PARVING H-H, Lambers-Heerspink H, de Zeeuw D
    Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
    N Engl J Med. 2016;375:1800-1.
    PubMed     Text format    


    Pediatr Diabetes

  71. REMEDI MS, Thomas M, Nichols CG, Marshall BA, et al
    Sulfonylurea challenge test in subjects diagnosed with type 1 diabetes mellitus.
    Pediatr Diabetes. 2017 Jan 23. doi: 10.1111/pedi.12489.
    PubMed     Text format     Abstract available

  72. NILSSON J, Akesson K, Hanberger L, Samuelsson U, et al
    High HbA1c at onset cannot be used as a predictor for future metabolic control for the individual child with type 1 diabetes mellitus.
    Pediatr Diabetes. 2017 Jan 24. doi: 10.1111/pedi.12498.
    PubMed     Text format     Abstract available

  73. DOST A, Bechtold-Dalla Pozza S, Bollow E, Kovacic R, et al
    Blood pressure regulation determined by ambulatory blood pressure profiles in children and adolescents with type 1 diabetes mellitus: Impact on diabetic complications.
    Pediatr Diabetes. 2017 Jan 24. doi: 10.1111/pedi.12502.
    PubMed     Text format     Abstract available

  74. STECK AK, Larsson HE, Liu X, Veijola R, et al
    Residual beta-cell function in diabetes children followed and diagnosed in the TEDDY study compared to community controls.
    Pediatr Diabetes. 2017 Jan 27. doi: 10.1111/pedi.12485.
    PubMed     Text format     Abstract available

  75. PIECHOWIAK K, Dzygalo K, Szypowska A
    The additional dose of insulin for high-protein mixed meal provides better glycemic control in children with type 1 diabetes on insulin pumps: randomized cross-over study.
    Pediatr Diabetes. 2017 Jan 24. doi: 10.1111/pedi.12500.
    PubMed     Text format     Abstract available


    PLoS One

  76. AHMED AS, Li J, Abdul AM, Ahmed M, et al
    Compromised Neurotrophic and Angiogenic Regenerative Capability during Tendon Healing in a Rat Model of Type-II Diabetes.
    PLoS One. 2017;12:e0170748.
    PubMed     Text format     Abstract available

  77. KHANDOKER AH, Al-Angari HM, Khalaf K, Lee S, et al
    Association of Diabetes Related Complications with Heart Rate Variability among a Diabetic Population in the UAE.
    PLoS One. 2017;12:e0168584.
    PubMed     Text format     Abstract available

  78. CUNNION KM, Krishna NK, Pallera HK, Pineros-Fernandez A, et al
    Complement Activation and STAT4 Expression Are Associated with Early Inflammation in Diabetic Wounds.
    PLoS One. 2017;12:e0170500.
    PubMed     Text format     Abstract available

  79. YANG HS, Woo JE, Kim MH, Kim DY, et al
    Co-Evaluation of Peripapillary RNFL Thickness and Retinal Thickness in Patients with Diabetic Macular Edema: RNFL Misinterpretation and Its Adjustment.
    PLoS One. 2017;12:e0170341.
    PubMed     Text format     Abstract available

  80. STOKES A, Preston SH
    Deaths Attributable to Diabetes in the United States: Comparison of Data Sources and Estimation Approaches.
    PLoS One. 2017;12:e0170219.
    PubMed     Text format     Abstract available

  81. KOLUMAM G, Wu X, Lee WP, Hackney JA, et al
    IL-22R Ligands IL-20, IL-22, and IL-24 Promote Wound Healing in Diabetic db/db Mice.
    PLoS One. 2017;12:e0170639.
    PubMed     Text format     Abstract available

  82. KAMRADT M, Krisam J, Kiel M, Qreini M, et al
    Health-Related Quality of Life in Primary Care: Which Aspects Matter in Multimorbid Patients with Type 2 Diabetes Mellitus in a Community Setting?
    PLoS One. 2017;12:e0170883.
    PubMed     Text format     Abstract available

  83. OKODUWA SI, Umar IA, James DB, Inuwa HM, et al
    Appropriate Insulin Level in Selecting Fortified Diet-Fed, Streptozotocin-Treated Rat Model of Type 2 Diabetes for Anti-Diabetic Studies.
    PLoS One. 2017;12:e0170971.
    PubMed     Text format     Abstract available


    Retina

  84. SAXENA S, Ruia S, Prasad S, Jain A, et al
    INCREASED SERUM LEVELS OF UREA AND CREATININE ARE SURROGATE MARKERS FOR DISRUPTION OF RETINAL PHOTORECEPTOR EXTERNAL LIMITING MEMBRANE AND INNER SEGMENT ELLIPSOID ZONE IN TYPE 2 DIABETES MELLITUS.
    Retina. 2017;37:344-349.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: